SI-BONE, Inc., a leading innovator in the orthopaedic industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2008, the company has made significant strides in developing advanced solutions for sacroiliac joint disorders, establishing itself as a trusted name in minimally invasive surgical techniques. The core offerings of SI-BONE include the iFuse Implant System, which is renowned for its unique design and effectiveness in stabilising the sacroiliac joint. This product has set a benchmark in the market, contributing to improved patient outcomes and reduced recovery times. With a strong focus on research and development, SI-BONE has achieved notable recognition for its commitment to innovation and quality, solidifying its position as a leader in the orthopaedic device sector.
How does SI-BONE, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SI-BONE, Inc.'s score of 20 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SI-BONE, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their Scope 1, 2, or 3 emissions. In the absence of concrete emissions data or reduction commitments, it is unclear how SI-BONE, Inc. is addressing climate change or its carbon footprint. The company may be in the early stages of developing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be important for SI-BONE, Inc. to establish clear climate commitments and emissions reduction targets to align with global efforts to mitigate climate change.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SI-BONE, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
